SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Piramal Pharma’s arm completes acquisition of ‘Kenalog’

01 Apr 2026 Evaluate

Piramal Pharma’s step-down wholly owned subsidiary -- Piramal Critical Care B.V. has successfully completed the acquisition of ‘Kenalog’ and its associated brands from Bristol-Myers Squibb Company (BMS).

With the completion of the Kenalog acquisition, the Company strengthens its Complex Hospital Generics portfolio and reinforces its presence across key markets including the United States, Europe, and Asia Pacific.

Piramal Pharma provides end-to-end pharma services to customers and a portfolio of differentiated pharma products across a domestic and global distribution network.

Piramal Pharma Share Price

165.10 5.30 (3.32%)
06-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1850.40
Dr. Reddys Lab 1310.50
Cipla 1365.25
Zydus Lifesciences 939.10
Lupin 2442.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×